If decision-makers do not understand obesity to be a long-term chronic disease, thats when we see these exclusionary policies or these very, very cumbersome utilization management practices that really just set up one barrier after another to prevent people from getting the care that they need
By addressing these complexities, we can optimize therapeutic outcomes and improve the quality of life of patients suffering from neurodegenerative diseases
The L-carnitine market is segmented into food & pharmaceuticals and feed grade based on the products
Risks include melanoma (skin cancer) and long, painful erections, says the FDA
The current GLP-1 standard of care gets a patient to their maximum amount of weight loss, but once that plateau is reached, there is no protocol for an appropriate reduced dose schedule to maintain that result or even to wean them off the medication, Dr